Diadema Partners »

Tarsus Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 26k 70.15

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Tarsus Pharmaceuticals

Deep Track Capital
BlackRock
Rtw Investments
Paradigm Biocapital Advisors
Henderson Group
Morgan Stanley
Vanguard Capital Management
Jennison Associates
Bank of America Corporation
Tang Capital Management
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Driehaus Capital Management
Lord, Abbett & Co

View all funds holding Tarsus Pharmaceuticals